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     Abstract   
Background: Extracorporeal shockwave lithotripsy (ESWL) has proved to be effective in treating ureterolithiasis. 
This study aimed to investigate the predictive factors related to success ESWL among patient presented with renal 
stone.   
Methods: A retrospective study was conducted among 40 patients who underwent ESWL at the urology 
department, Baquba Teaching Hospital, Diyala University, Iraq. Data was collected between 1st October 2018 and 
31st January 2019 for renal stones diagnosed by non-enhanced spiral computed tomography (NCCT). The 
success rate defined as no stone or the remnant stones < 4 mm. We analyzed predictive factors by using multiple 
linear regression. 
Results: The success rates ranged from 50-90%. In the univariate analysis, body mass index (BMI), skin-to-stone 
distance (SSD) and the renal stone-attenuation value (in Hounsfield units, HU) were found to be significantly 
correlated with the outcome of ESWL (p<0.05). However, in the multiple linear regression, only the HU (B = -0.619, 
P < 0.0001; 95% confidence interval [CI]: 0.03 to 0.07) was the independent predictive factor. 
Conclusion: Hounsfield Unit is an independent predictive factor influencing the success of ESWL for treating renal 
stones. 
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Background   
Some facts and figures cannot overcome when discussing the 
issue of renal calculi and ureteral calculi (ureterolithiasis). First, 
the incidence rate is increasing at the global level regardless of 
region, race, gender, and age [1]. Second, diagnosis often 
delayed when the stone is large enough to affect the function of 
the urinary tract system [2]. Third, the significant change in 
lifestyle and bad dietary habits have emerged as other 
complicating factors in the way of treatment [3]. Fourth, the 
lack of awareness about the causes and the risk of urinary tract 
stones among most people [4]. Fifth, there is a misconception 
that when removing stone by any way of treatment means full 
recovery. Unfortunately, the recurrence rate is high [5]. Sixth, 
the magnitude of ureterolithiasis goes beyond the health and 
psychological impact on serious economic and social 
repercussions [6]. Seventh, the technological advances in 
diagnosis and treatment of ureterolithiasis, especially the 
introduction of non‐contrast computed tomography (NCCT) and 
extracorporeal shockwave lithotripsy (ESWL) in the early 
1980s, increased the chances of early diagnosis and the safe 
treatment with fewer side effects [7].  
     Eighths, NCCT is superior to Intravenous Urogram (IVU) in 
the sensitivity and specificity regarding the diagnosis of the 
renal and ureteral calculi. However, NCCT’s safety is not 
guaranteed due to the high radiation dose [8]. Ninth, the success 
and failure rate of ESWL have been extensively discussed in 
previous research and most of them revolved around the age of 
patient, gender, body mass index (BMI), stone size, location, 
the skin-to-stone distance (SSD), the renal stone-attenuation 
value (in Hounsfield units, HU), and presence or absence of 
complications and so on. In this current study, we are also 
trying to find out the most important predicting factors for the 
success of the ESWL procedure among sample of Iraqi patients 
presented with renal stone.  
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Methods 
A retrospective analysis was performed among 40 patients who 
underwent ESWL between 1st October 2018 and 31st January 
2019 for renal stones at the urological department of Baquba 
Teaching Hospital. A non-enhanced spiral computed 
tomography (NESCT) was used to diagnose the included cases.  
 
Table 1 Inclusion and exclusion criteria    
No. The Main Criteria Inclusion & 
Exclusion 
1. Stone size >4 mm + 
2. Solitary stones + 
3. Radiopaque stones on the pretreatment plain 
radiography 
+ 
4. Stone < 20mm + 
5. Ongoing urinary tract infections - 
6. Blood coagulation disorders - 
7. Ureteral Stricture - 
8. Neurogenic bladder - 
9. Polycystic kidney - 
10. Multiple stones - 
11. Obstructed stones with severe grades of 
hydronephrosis 
- 
12. Renal failure - 
13. Pregnancy  - 
(+) Inclusion criteria, (-) Exclusion criteria 
 
Patient age, gender, body mass index (BMI), stone size, 
location, skin-to-stone distance (SSD), Hounsfield unit (HU) 
were the main variables recruited to predict the successful 
procedure of ESWL (Table 2). 
     For each patient, height in meters and weight in kilogram 
were measured to calculate the BMI following the formula: 
“BMI = kg/m2 where kg is a patient’s weight in kilograms and 
m2 is their height in meters squared". An average of three 
different measures (0°, 45°, and 90°) from the skin to renal 
stone has been taken on NESCT to determine the SSD for each 
stone. The stone attenuation values (Hounsfield units [HU]) 
were measured following the steps described by Choi et al. [9]. 
The first step was to obtain images using the Non-enhanced 
helical technique by considering the 5-mm collimation breadth 
from the tip of the kidneys to the level of the pubic symphysis. 
The second step was to analyze the stones in largest dimension, 
where three regions of interest (ROI) with similar-size ROI 
(2.0±0.5 mm2) were considered. In the third step, the average 
measure of three ROIs was considered as the HU for that stone. 
     All patients were planned for second NCCT 30 days after the 
ESWL to assess the success rate and to check for the possible 
complications. In this study, the success rate of ESWL was 
considered when the targeted stone disappeared completely 
(stone free) or with remaining of residual stone fragments of 
less than 4 mm size as clinically insignificant remaining 
fragments (CIRF). However, residuals fragments of ≥4 mm 
considered the sign for the failure of ESWL. 
     ESWL procedure performed under pethidine sedation and 
the supervision of a urologist by using an electroconductive 
lithotriptor (Sonolith Praktis, EDAP TMS, Vaulx-en-Velin, 
France). The stones fragmented under fluoroscopic guidance. 
When there was a large fragment with a long diameter >4 mm, 
ESWL was tried repeatedly until each fragment became smaller 
than 4 mm. The failure of ESWL was defined as remnant stones 
larger than 4 mm at three months after the first session. 
 
Statistical analysis 
Descriptive data presented as the mean (SD). Univariate 
analysis was used to assess the association between the various 
factors and outcomes. An independent sample t‐test was used to 
compare means between the categorical variable, e.g., gender 
and stone location with Stone Free Rate. Pearson correlation 
coefficient was used to test the relation between the continuous 
variables, e.g., age, BMI, stone size, skin to stone distance and 
the values of the Hounsfield unit and the outcome Stone Free 
Rate. After that, the significantly associated variables were 
tested with multiple linear regression analysis to identify the 
independent predictors of successful treatment. Statistical 
analysis performed by using SPSS ver. 16.0 (SPSS Inc., 
Chicago, IL, USA). Values of p<0.05 were considered 
statistically significant. 
 
Results  
Descriptive analyses (univariate analysis) 
Table 1 presents the descriptive characteristics of the socio-
demographic variables. The patient means age (±SD) was 44.36 
years (±1.80) (range, 11 to 78 years). More than half of 
respondent (23, 57.5%) were females and an average BMI 
25.23(±3.42). Most of the patients presented with left side (22, 
55.0%) renal stone with a mean stone size of 11.48 (±2.23) and 
average skin-to-stone distance of 80.23(±1.76) mm. The density 
of stones was in average Hounsfield unit of 7.1(±1.44) and 
average Stone Free Rate of 65.75(±11.74). 
 
     An independent sample t-test was used to compare the mean 
of stone free rate scores across demographic and other 
variables. There were no significant differences between the 
gender, stone location and the Stone Free Rate (Table 3). 
 
     Table 4 presents the results of the Pearson correlation 
coefficient with stone free rate. Two variables; SSD, and the 
HU found to be correlated significantly with stone free rate. 
 
Multivariate analysis  
Predictors of fragmentation 
Table 5 shows the results of multiple linear regression analysis 
to identify the associated variables with the stone-free rate. In 
backward elimination (or backward deletion) the multivariate 
linear regression analysis (after excluding of non-contributing 
variables) was statistically significant, and overall, explained 
38.3% of the variance in the stone-free rate, F (38, 23.591) = 
2059.753, P < 0.0005. The “Hounsfield unit” appeared to be the 
only factors predicting the stone-free rate (Table 5). The high 
numbers of Hounsfield unit were more likely to have a low 
stone-free rate (B = -0.619, P < 0.001). 
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Table 2 Descriptive statistic of socio-demographic and other variables (n=40)
No. Variables  Category  Mean (±SD) Range N% 
1 Age  - 44.36 (SD 1.80)  (11-78) - 
2 Gender  Male  - - 17 (42.5) 
  Female  - - 23 (57.5) 
3 Body Mass Index (BMI) - 25.23 (SD 3.42) (16.96-34.96)  
4 Stone Location Right side - - 18 (45.0) 
  Left side - - 22 (55.0) 
5 Stone Size  - 11.48(SD 2.23)  (7-20) - 
6 Skin- to- Stone Distance (SSD) - 80.23 (SD1.76)  (50-124) - 
7 Hounsfield Unit (HU) - 7.1 (SD1.44) (500-990) - 
8 Stone Free Rate - 65.75 (SD 11.74)  (50-90) - 
 
 
 
Table 3 An-independent sample t-test on stone free rate (n=40)
No. Variables  Category  N% Mean + SD t-test P-value 
95% Upper-
Lower 
1 Gender  Male  17 (42.5) 62.9 (10.5) 1.347 0.186 2.5-12.2 
  Female  23 (57.5) 67.8 (12.4)    
2 Stone Site  Right  18 (45.0) 65.6 (12.9) 0.092 0.927 7.5-8.2 
  Left  22 (55.0) 65.9 (11.0)    
 
Table 4 Pearson correlation coefficient on stone free rate (n=40)
No. Variables R value Sig (2-tailed) 
1 Age (years) 0.126 0.437 
2 Body Mass Index (BMI) 0.251 0.118 
3 Stone size (mm) 0.107 0.511 
4 Skin-to-stone distance (mm) 0.402* 0.010 
5 Hounsfield Unit (HU) 0.619* 0.000 
Table 5 Results of multiple linear regression on stone free rate (n=40) 
Variables  B  S.E. Beta  t-test Sig. 95% CI Lower-Upper Tolerance  VIF  
Constant  101.563 7.520 - 13.506 0.000 86.3-116.8 - - 
Hounsfield Unit -0.050 0.010 -0.619 -4.875 0.000 0.03-0.07 0.662 1.511 
 
Discussion 
There is an agreement among urologists that ESWL contributed 
significantly to reducing the patient suffering and accelerating 
the treatment. High success rates of ESWL reported around the 
world associated with promising outcomes in terms of low cost, 
less length of patient stay (LOS) and minimal side effects [10]. 
In the current study, the success rate of ESWL was on average 
of 65.75 (SD 11.74) which in line to findings reported by 
Assimos et al [11]. In this study, a high correlation (r =0.619) 
between the HU and SFR and in multiple linear regression only 
HU (p<0.001) was significantly predicting the rate of SF. 
Similarly, Berber-Deseusa et al [12] found that there was a 
statistically significant relationship between the HU and the 
success of ESWL (p = 0.01) (OR 6; 95% CI: 1.4-26.2). 
Massoud et al [7] concluded that the failure rate of ESWL 
would be more than half when treating the patients presented 
with the stone of 1000 HU or more. The author argued that in 
such case ESWL should not be considered as a first line in the 
treatment. In our sample, the renal stone-attenuation value was 
within the acceptable range of (500 to 990) for ESWL 
procedure [7]. Part of our study analysis showed weak 
correlation (r =0.308) between the weight of patients and SFR. 
Many studies discussed obesity and its relationship to the 
success of the ESWL procedure; the higher the obesity, the 
lower the success rate [13,14]. Obesity is associated with 
increased absorption of radiation and difficulty in locating the 
calculi [13]. Pareek et al [15] found that both BMI and HU are 
independent predictors for successful SEWL. However, in 
respect to our findings, Dede et al [13], Bulent et al [14] and 
Pompeo et al [16] reported in different studies that BMI does 
not affect SFR. Moreover, Bulent et al [14] and Pareek et al 
[15] found a significant relationship between the SSD and the 
success of ESWL. 
     Similarly, in our study, moderate correlation (r=0.402) was 
reported between the SSD and SFR. However, Jacobs et al [17] 
found that SSD did not have a statistically significant effect on 
the success of ESWL treatment. Although the results of our 
study found that the size of stone has no relation to the success 
of the ESWL procedure, however this finding conflict with 
previous results confirmed that the size of renal stone has a 
direct impact on the SFR [9,18]. Whenever the size of the stone 
was larger the possibility of ESWL failure is high. Joshi et al 
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[19] concluded that for the stone size of less than 15 mm the 
likelihood of SFR is high. Location of stone within the different 
parts of the kidney may alter the skin to stone distance 
especially when associated with high. Two studies carried out in 
Egypt [7], and Oman [20] indicated that the success rate of 
ESWL decreased significantly when the stone location was in 
lower calyceal. Dede et al [13] reported that the position of 
stone (right or lift kidney) was not related to the rate of SF 
which is in line to our findings. Concerning the 
sociodemographic factors, age appeared to have no impact on 
the outcome of ESWL. Similar results were reported in Oman 
[20]. Previous studies conducted by Lee et al [21] found that 
there were no significant differences between men and women 
patients concerning the success of ESWL, which is in line with 
our current findings. However, Shinde et al [20] found a 
significant gender difference, and the success rate was higher 
among men. The author also found that women patients were 
less tolerated for treatment than men [20]. The retrospective 
design and the inclusion of a small number of patients (only the 
successfully treated cases) led to a selection bias as the main 
limitation for this research. 
 
Conclusion 
In conclusion, the results of this study added another event that 
the renal stone-attenuation value (in Hounsfield units, HU) is 
the most potent predictor for successful ESWL. Moreover, there 
is a significant, but in reverse, the relationship between the 
value of HU and the stone-free rate. 
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